Novel 1,4-benzothiazephine and 1,5-benzothiazepine compounds as inhibitors of apical sodium co-dependent bile acid transport and taurocholate uptake
申请人:——
公开号:US20020183307A1
公开(公告)日:2002-12-05
Compounds, pharmaceutical compositions, and methods for the treatment of a hyperlipidemic condition in a subject. The compounds of the present invention are apical sodium co-dependent bile acid transport inhibitors and are 1,4-benzothiazepine and 1,5-benzothiazepine compounds corresponding to Formula I:
1
wherein j, m, Y, Z, R
1A
, R
1B
, R
2A
, R
2B
and R
6
are as defined in the specification.
本发明涉及用于治疗主题的高脂血症状况的化合物、药物组合物和方法。本发明的化合物是顶端钠依赖性胆汁酸转运抑制剂,是与式I:1相应的1,4-苯并噻吩和1,5-苯并噻吩化合物,其中j、m、Y、Z、R1A、R1B、R2A、R2B和R6如规范中所定义。